American Psychiatric Association (1994) Diagnostic and Statistical Manual (4th edn) . Washington, DC: APA.
Barrowclough, C. & Tarrier, N. (1992) Families of Schizophrenic Patients: A Cognitive–Behavioural Intervention. London: Chapman and Hall.
Barrowclough, C., Marshall, M., Lockwood, A., et al (1998) Assessing relatives' needs for psychosocial interventions in schizophrenia: a relative version of the Cardinall Needs Schedule (RCNS). Psychological Medicine, 28, 531–542.
Barrowclough, C., Haddock, G., Tarrier, N., et al (2000) Cognitive behavioural intervention for clients with severe mental illness who have a substance misuse problem. Psychiatric Rehabilitation Skills, 4, 216–233.
Barrowclough, C., Haddock, G., Tarrier, N., et al (2001) Randomised controlled trial of cognitive behavioural therapy plus motivational intervention for schizophrenia and substance use. American Journal of Psychiatry, 158, 1706–1713.
Beck, A. T., Ward, C. H., Mendelson, M., et al (1961) An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.
Birchwood, M., Smith, J., Cochrane, R., et al (1990) The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry, 157, 853–859.
British Medical Association & Royal Pharmaceutical Society of Great Britain (1999) British National Formulary
. London & Wallingford: BMJ Books & Pharmaceutical Press.
Claxton, K. (1999) The irrelevance of inference: a decision making approach to the stochastic evaluation of health care technologies. Journal of Health Economics, 18, 341–364.
Cormac, I., Jones, C., Campbell, C., et al (2003) Cognitive behaviour therapy for schizophrenia. Cochrane Library, issue 1. Oxford: Update Software.
Delaney, B. C., Wilson, S., Roberts, L., et al (2000) Cost-effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet, 356, 1965–1969.
Everitt, B. S. & Pickles, A. (1999) Statistical Aspects of the Design and Analysis of Clinical Trials. London: Imperial College Press.
Goldberg, D. & Williams, P. A. (1988) A User's Guide to the General Health Questionnaire. Windsor: NFER–Nelson.
Haddock, G. & Tarrier, N. (1998) Assessment and formulation in the cognitive behavioural treatment of psychosis. In Treating Complex Cases: The Cognitive Behavioural Therapy Approach (eds Tarrier, N., Wells, A. & Haddock, G.), pp. 155–175. Chichester: Wiley.
Haddock, G., Devane, S., Bradshaw, T., et al (2001) An investigation into the psychometric properties of the Cognitive Therapy Scale for Psychosis (CTS-Psy). Behavioural and Cognitive Psychotherapy, 29, 221–233.
Haddock, G., Barrowclough, C., Moring, J., et al (2002) Cognitive–behaviour therapy for patients with coexisting psychosis and substance use problems. In A Casebook of Cognitive Therapy for Psychosis (ed. Morrison, A. P.), pp. 265–280. Chichester: Wiley.
Kay, S., Fiszbein, A. & Opler, L. (1988) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–275.
Knapp, M. & Beecham, J. (1990) Costing mental health services: The Client Service Receipt Inventory. Psychological Medicine, 20, 893–908.
Leff, J. & Vaughan, C. (1985) Expressed Emotion in Families: Its Significance for Mental Illness. New York: Guilford Press.
Ley, A., Jeffery, D. P., McLaren, S., et al (2001) Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Library, issue 2. Oxford: Update Software.
McLellan, A. T., Luborsky, L., Woody, G. E., et al (1980) An improved evaluation instrument for substance abuse patients: the Addiction Severity Index. Journal of Nervous and Mental Disease, 168, 26–33.
Miller, W. R. & Rollnick, S. (1991) Motivational Interviewing: Preparing People to Change Addictive Behaviour. New York: Guilford Press.
Mueser, K. T., Yarnold, P. R., Levinson, D. F., et al (1992) Prevalence of substance use in schizophrenia: demographic and clinical correlates. Schizophrenia Bulletin, 16, 31–56.
Netten, A., Dennet, J. & Knight, J. (1999) Unit Costs of Health and Social Care. Canterbury: University of Kent, Personal Social Services Research Unit.
Pilling, S., Bebbington, P., Kuipers, E., et al (2002) Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine, 32, 763–782.
Platt, S., Weyman, A., Hirsch, S. R., et al (1980) The Social Behaviour Assessment Schedule (SBAS): rationale, contents, scoring and reliability. Social Psychiatry, 15, 43–55.
Schofield, N., Quinn, J., Haddock, G., et al (2001) Schizophrenia and substance use problems: a comparison between patients with and without significant carer contact. Social Psychiatry and Psychiatric Epidemiology, 36, 523–528.
Searles, J. S., Alterman, A. L. & Purtill, J. J. (1990) The detection of alcoholism in hospitalized schizophrenics: a comparison of the MAST and the MAC. Alcoholism: Clinical and Experimental Research, 14, 557–560.
Sobell, L. C. & Sobell, M. B. (1992) Timeline follow-back: a technique for assessing self-reported alcohol consumption. In Measuring Alcohol Addiction (eds Litten, R. & Allen, J.). Totowa, NJ: Humana Press.
Staley, D. & el-Guebaly, N. (1990) Psychometric properties of the Drug Abuse Screening Test in a psychiatric patient population. Addictive Behaviour, 15, 257–264.
STATACorp (1997) Stata Statistical Software. College Station, TX: Stata Corporation.
Thompson, S. G. & Barber, J. A. (2000) How should cost data in pragmatic randomised controlled trials be analysed?
BMJ, 320, 1197–2000.
UK Prospective Diabetes Study Group (1998) Cost-effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ, 317, 720–726.
Van Hout, B. A., Al, M. J., Gordon, G. S., et al (1994) Costs, effects and c/e-ratios alongside a clinical trial. Health Economy, 3, 309–319.
World Health Organization (1992) Tenth Revision of the International Classification of Diseases and Related Health Problems
. Geneva: WHO.